These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26436915)

  • 1. Assessing Biases in the Evaluation of Classification Assays for HIV Infection Recency.
    Patterson-Lomba O; Wu JW; Pagano M
    PLoS One; 2015; 10(10):e0139735. PubMed ID: 26436915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the accuracy of the Asanté assay as a point-of-care rapid test for HIV-1 recent infections using serum bank specimens from blood donors in South Africa, July 2018 - August 2021.
    Singh B; Mthombeni J; Olorunfemi G; Goosen M; Cutler E; Julius H; Brukwe Z; Puren A
    S Afr Med J; 2023 Oct; 113(10):42-48. PubMed ID: 37881912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
    Facente SN; Grebe E; Maher AD; Fox D; Scheer S; Mahy M; Dalal S; Lowrance D; Marsh K
    JMIR Public Health Surveill; 2022 Mar; 8(3):e34410. PubMed ID: 35275085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.
    Moyo S; Vandormael A; Wilkinson E; Engelbrecht S; Gaseitsiwe S; Kotokwe KP; Musonda R; Tanser F; Essex M; Novitsky V; de Oliveira T
    PLoS One; 2016; 11(8):e0160649. PubMed ID: 27552218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.
    Carlisle LA; Turk T; Metzner KJ; Mbunkah HA; Shah C; Böni J; Huber M; Braun DL; Fehr J; Salazar-Vizcaya L; Rauch A; Yerly S; Nguyen A; Cavassini M; Stoeckle M; Vernazza P; Bernasconi E; Günthard HF; Kouyos RD
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33142675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Generalized Entropy Measure of Within-Host Viral Diversity for Identifying Recent HIV-1 Infections.
    Wu JW; Patterson-Lomba O; Novitsky V; Pagano M
    Medicine (Baltimore); 2015 Oct; 94(42):e1865. PubMed ID: 26496342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying major drivers of incident HIV infection using recent infection testing algorithms (RITAs) to precisely inform targeted prevention.
    Zhu Q; Wang Y; Liu J; Duan X; Chen M; Yang J; Yang T; Yang S; Guan P; Jiang Y; Duan S; Wang J; Jin C
    Int J Infect Dis; 2020 Dec; 101():131-137. PubMed ID: 32987184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing high-throughput HIV incidence assay with pyrosequencing platform.
    Park SY; Goeken N; Lee HJ; Bolan R; Dubé MP; Lee HY
    J Virol; 2014 Mar; 88(5):2977-90. PubMed ID: 24371062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
    Keating SM; Kassanjee R; Lebedeva M; Facente SN; MacArthur JC; Grebe E; Murphy G; Welte A; Martin JN; Little S; Price MA; Kallas EG; Busch MP; Pilcher CD
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):581-588. PubMed ID: 27509247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision detection of recent HIV infections using high-throughput genomic incidence assay.
    Faraci G; Park SY; Love TMT; Dubé MP; Lee HY
    Microbiol Spectr; 2023 Sep; 11(5):e0228523. PubMed ID: 37712639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short Communication: Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda.
    Galiwango RM; Ssuuna C; Kaleebu P; Kigozi G; Kagaayi J; Nakigozi G; Reynolds SJ; Lutalo T; Kankaka EN; Wasswa JB; Kalibbala SN; Kigozi AN; Watera C; Ejang J; Ndyanabo A; Anok AJ; Ssemwanga D; Kibengo FM; Quinn TC; Grabowski M; Chang LW; Wawer M; Gray R; Laeyendecker O; Serwadda D
    AIDS Res Hum Retroviruses; 2021 Dec; 37(12):893-896. PubMed ID: 33499732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent HIV-1 infection in Israel 2017-2021: Evaluation of geenius and HIV-1/2 combo assays for identifying recent infection detected by Sedia assay and assessment of factors related to recent infection: Recent HIV-1 infection in Israel.
    Azuri E; Wax M; Gozlan Y; Wagner T; Mor O
    J Clin Virol; 2024 Feb; 170():105624. PubMed ID: 38118239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.
    Park SY; Love TMT; Reynell L; Yu C; Kang TM; Anastos K; DeHovitz J; Liu C; Kober KM; Cohen M; Mack WJ; Lee HY
    Sci Rep; 2017 Aug; 7(1):7480. PubMed ID: 28785052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an avidity assay for detection of recent HIV infections.
    Shepherd SJ; McAllister G; Kean J; Wallace LA; Templeton KE; Goldberg DJ; Gunson RN; Aitken C
    J Virol Methods; 2015 Jun; 217():42-9. PubMed ID: 25721468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.